2022. Negative Effect on the Anti-Oxidant Potential of Cilnidipine in Breast Cancer Cell Lines – An in Vitro Study. Journal of Pharmaceutical Negative Results. (Dec. 2022), 2070–2075. DOI:https://doi.org/10.47750/pnr.2022.13.S06.270.